Harnessing the UK’s genomics expertise to improve patient outcomes

This ABPI report describes both the strengths and weaknesses of the UK’s genomics offer, identifying how the sector can work together to attract further investment and deliver an enhanced offer for patients and their families.

Sep 2024. This report was updated to make a minor change in the text.